Biliary Tract Cancer
Conditions
Interventions
Sponsors
Yantai Yuhuangding Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with pathologically confirmed biliary tract cancer; 2.Patients who had received at least two cycles of immunotherapy, with efficacy evaluations performed every two cycles according to the Response Evaluation Criteria in Solid Tumors (RECIST v1.1); 3.Patients with complete pre-treatment clinical information, complete MRI images, and complete pathological whole-slide imaging (WSI) data; 4.Patients with no history of other primary malignancies; 5.Patients aged >=18 years and <= 80 years at the time of diagnosis.
Exclusion criteria
Exclusion criteria: 1.Patients with other primary malignancies; 2.Patients with severe autoimmune diseases or organ failure that may interfere with the assessment of treatment efficacy; 3.Patients who discontinued immunotherapy due to non-progressive causes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival (OS);Objective Response Rate (ORR);Progression-Free Survival (PFS);Disease Control Rate (DCR);Area Under the Curve;Concordance index; | — |
Countries
China
Contacts
Public ContactLiu Aina
Yantai Yuhuangding Hospital
Outcome results
None listed